The_DT role_NN of_IN advertisments_NNS in_IN purchasing_VBG behaviour_NN of_IN consumer_NN for_IN any_DT product_NN is_VBZ continously_RB rising_VBG from_IN a_DT long_JJ time_NN ._.
It_PRP is_VBZ true_JJ that_IN advertisments_NNS make_VBP product_NN 's_POS feature_NN or_CC chracterstic_JJ much_RB better_JJR than_IN they_PRP really_RB are_VBP ._.
I_PRP am_VBP strongly_RB agree_VB with_IN this_DT statment_NN because_IN of_IN number_NN of_IN valid_JJ reasons_NNS and_CC examples_NNS ._.
It_PRP affects_VBZ consumers_NNS and_CC manufacturer_NN in_IN number_NN of_IN ways_NNS ._.
First_RB ,_, financial_JJ importance_NN of_IN advertisment_NN to_TO manufacturer_NN of_IN product_NN ._.
Any_DT manufacturer_NN of_IN products_NNS want_VBP to_TO sell_VB his_PRP$ products_NNS to_TO earn_VB the_DT money_NN or_CC profit_NN out_IN of_IN that_DT process_NN ._.
To_TO introduce_VB a_DT new_JJ product_NN or_CC stand_VB with_IN competition_NN with_IN other_JJ providers_NNS they_PRP usually_RB needs_VBZ to_TO advertise_VB the_DT product_NN ._.
Advertisment_NN are_VBP usually_RB an_DT expensive_JJ way_NN of_IN promotion_NN ._.
Therefore_RB ,_, manufacturer_NN use_VBP the_DT best_JJS part_NN of_IN products_NNS to_TO highlight_VB in_IN advertisments_NNS ._.
They_PRP usually_RB hides_VBZ the_DT negative_JJ part_NN of_IN products_NNS ._.
Thus_RB consumer_NN usally_RB disguised_VBN by_IN claims_NNS made_VBN by_IN product_NN in_IN advetisments_NNS ._.
On_IN the_DT other_JJ hand_NN advertisements_NNS are_VBP also_RB in_IN favour_NN of_IN consumers_NNS ._.
These_DT promotional_JJ activities_NNS make_VBP them_PRP aware_JJ of_IN new_JJ products_NNS and_CC selective_JJ features_NNS of_IN products_NNS ._.
Second_RB ,_, effects_NNS of_IN advertisements_NNS on_IN consumer_NN ._.
Advertisments_NNS in_IN pharmaceutical_JJ industry_NN usually_RB shows_VBZ the_DT postive_JJ features_NNS of_IN any_DT drug_NN ._.
Advertisments_NNS of_IN drug_NN Vioxx_NNP by_IN Merck_NNP Labs_NNPS never_RB talked_VBD about_IN the_DT harmfull_NN affect_NN of_IN drug_NN on_IN cardiovascular_JJ system_NN on_IN patients_NNS ._.
These_DT advertisments_NNS increase_VBP the_DT usage_NN of_IN drugs_NNS in_IN consumer_NN and_CC ended_VBD up_RP with_IN serious_JJ effects_NNS on_IN blood_NN system_NN ._.
On_IN the_DT other_JJ hand_NN advertisments_NNS helps_VBZ consumers_NNS or_CC patients_NNS about_IN the_DT availability_NN of_IN various_JJ treatment_NN options_NNS ._.
After_IN the_DT advertisments_NNS of_IN drugs_NNS from_IN Pharmaceutical_NNP company_NN ,_, patient_NN come_VBN to_TO know_VB about_IN the_DT underlying_VBG disease_NN and_CC check_VB with_IN their_PRP$ physicains_NNS for_IN availabilty_NN of_IN treatment_NN option_NN ._.
Therefore_RB ,_, advertisments_NNS improves_VBZ the_DT quality_NN of_IN life_NN for_IN some_DT patients_NNS ._.
To_TO sum_VB up_RP ,_, we_PRP can_MD say_VB that_IN advertisment_NN usually_RB hides_VBZ the_DT negative_JJ feature_NN of_IN product_NN ._.
But_CC on_IN other_JJ side_NN it_PRP is_VBZ beneficial_JJ for_IN both_DT manufacturer_NN as_RB well_RB as_IN consumers_NNS ._.
Advertisements_NNS give_VBP more_JJR chance_NN to_TO growth_NN and_CC innovation_NN ._.
